unilever plc - UNLYF

UNLYF

Close Chg Chg %
56.73 -0.35 -0.62%

Open Market

56.38

-0.35 (0.62%)

Volume: 368.00

Last Updated:

Dec 27, 2024, 10:36 AM EDT

Company Overview: unilever plc - UNLYF

UNLYF Key Data

Open

$56.83

Day Range

56.38 - 56.83

52 Week Range

46.10 - 68.22

Market Cap

$139.57B

Shares Outstanding

2.48B

Public Float

2.43B

Beta

0.41

Rev. Per Employee

N/A

P/E Ratio

19.65

EPS

$1.81

Yield

328.95%

Dividend

$0.48

EX-DIVIDEND DATE

Nov 7, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

12.81K

 

UNLYF Performance

1 Week
 
0.00%
 
1 Month
 
-9.06%
 
3 Months
 
-7.88%
 
1 Year
 
18.25%
 
5 Years
 
-1.95%
 

UNLYF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

About unilever plc - UNLYF

Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever on January 1, 1930 and is headquartered in London, the United Kingdom.

UNLYF At a Glance

Unilever Plc
Unilever House
London, Greater London EC4Y 0DY
Phone 44-207-822-5252 Revenue 64.44B
Industry Household/Personal Care Net Income 7.01B
Sector Consumer Non-Durables 2023 Sales Growth 2.065%
Fiscal Year-end 12 / 2024 Employees 128,000
View SEC Filings

UNLYF Valuation

P/E Current 19.655
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 17.378
Price to Sales Ratio 1.904
Price to Book Ratio 6.054
Price to Cash Flow Ratio 12.562
Enterprise Value to EBITDA 12.111
Enterprise Value to Sales 2.339
Total Debt to Enterprise Value 0.21

UNLYF Efficiency

Revenue/Employee 503,428.238
Income Per Employee 54,790.601
Receivables Turnover 9.406
Total Asset Turnover 0.775

UNLYF Liquidity

Current Ratio 0.762
Quick Ratio 0.544
Cash Ratio 0.251

UNLYF Profitability

Gross Margin 42.237
Operating Margin 16.662
Pretax Margin 15.281
Net Margin 10.883
Return on Assets 8.44
Return on Equity 34.808
Return on Total Capital 13.596
Return on Invested Capital 15.435

UNLYF Capital Structure

Total Debt to Total Equity 157.955
Total Debt to Total Capital 61.234
Total Debt to Total Assets 37.989
Long-Term Debt to Equity 130.881
Long-Term Debt to Total Capital 50.738
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Unilever Plc - UNLYF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
57.82B 61.99B 63.14B 64.44B
Sales Growth
-0.61% +7.20% +1.85% +2.06%
Cost of Goods Sold (COGS) incl D&A
32.70B 35.77B 37.74B 37.22B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.30B 2.06B 1.81B 1.71B
Depreciation
1.92B 1.74B 1.54B 1.46B
Amortization of Intangibles
379.61M 323.86M 276.41M 246.49M
COGS Growth
+0.39% +9.38% +5.51% -1.36%
Gross Income
25.13B 26.22B 25.40B 27.22B
Gross Income Growth
-1.88% +4.37% -3.14% +7.16%
Gross Profit Margin
+43.45% +42.30% +40.23% +42.24%
2020 2021 2022 2023 5-year trend
SG&A Expense
14.45B 14.83B 15.22B 16.48B
Research & Development
911.98M 1.00B 954.28M 1.03B
Other SG&A
13.53B 13.83B 14.27B 15.45B
SGA Growth
-0.18% +2.67% +2.63% +8.27%
Other Operating Expense
- - - -
-
Unusual Expense
908.56M 1.23B 1.20B 652.99M
EBIT after Unusual Expense
9.77B 10.16B 8.98B 10.08B
Non Operating Income/Expense
(116.28M) 325.04M 2.49B 908.14M
Non-Operating Interest Income
264.47M 173.75M 295.32M 477.85M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
737.56M 600.45M 821.86M 1.14B
Interest Expense Growth
-13.63% -18.59% +36.88% +39.31%
Gross Interest Expense
737.56M 600.45M 821.86M 1.14B
Interest Capitalized
- - - -
-
Pretax Income
8.92B 9.89B 10.65B 9.85B
Pretax Income Growth
-1.85% +10.90% +7.67% -7.50%
Pretax Margin
+15.42% +15.95% +16.86% +15.28%
Income Tax
2.19B 2.29B 2.17B 2.38B
Income Tax - Current - Domestic
2.60B 2.55B 2.38B 2.43B
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(409.25M) (258.85M) (209.14M) (57.30M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
6.92B 7.83B 8.69B 7.72B
Minority Interest Expense
560.87M 676.09M 658.96M 705.97M
Net Income
6.36B 7.15B 8.03B 7.01B
Net Income Growth
+1.06% +12.38% +12.33% -12.68%
Net Margin Growth
+11.00% +11.53% +12.72% +10.88%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
6.36B 7.15B 8.03B 7.01B
Preferred Dividends
- - - -
-
Net Income Available to Common
6.36B 7.15B 8.03B 7.01B
EPS (Basic)
2.428 2.75 3.1519 2.7875
EPS (Basic) Growth
+0.91% +13.26% +14.61% -11.56%
Basic Shares Outstanding
2.62B 2.60B 2.55B 2.52B
EPS (Diluted)
2.4193 2.7398 3.1376 2.7694
EPS (Diluted) Growth
+0.94% +13.25% +14.52% -11.74%
Diluted Shares Outstanding
2.63B 2.61B 2.56B 2.53B
EBITDA
12.98B 13.45B 11.99B 12.44B
EBITDA Growth
-2.79% +3.66% -10.88% +3.78%
EBITDA Margin
+22.44% +21.70% +18.99% +19.31%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 63.207
Number of Ratings 22 Current Quarters Estimate 3.768
FY Report Date 12 / 2024 Current Year's Estimate 3.093
Last Quarter’s Earnings N/A Median PE on CY Estimate N/A
Year Ago Earnings 2.798 Next Fiscal Year Estimate 3.297
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 N/A 20 20
Mean Estimate 3.77 N/A 3.09 3.30
High Estimates 6.16 N/A 3.19 3.53
Low Estimate 1.37 N/A 2.94 3.13
Coefficient of Variance 89.92 N/A 2.03 3.21

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 11 12
OVERWEIGHT 2 2 1
HOLD 6 6 7
UNDERWEIGHT 1 1 1
SELL 2 2 2
MEAN Overweight Overweight Overweight

Unilever Plc in the News